The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology

Detalhes bibliográficos
Autor(a) principal: Belo, Rita F.
Data de Publicação: 2020
Outros Autores: Martins, Margarida L. F., Shvachiy, Liana, Costa-Coelho, Tiago, de Almeida-Borlido, Carolina, Fonseca-Gomes, João, Neves, Vera, Vicente Miranda, Hugo, Outeiro, Tiago F., Coelho, Joana E, Xapelli, Sara, Valente, Cláudia A., Heras, Montserrat, Bardaji, Eduard, Castanho, Miguel A. R. B., Diógenes, Maria José, Sebastião, Ana M
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/46303
Resumo: Copyright © 2020 Belo, Martins, Shvachiy, Costa-Coelho, de Almeida-Borlido, Fonseca-Gomes, Neves, Vicente Miranda, Outeiro, Coelho, Xapelli, Valente, Heras, Bardaji, Castanho, Diogenes and Sebastião. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
id RCAP_02b8ead87b309feb95d1df64de786b96
oai_identifier_str oai:repositorio.ul.pt:10451/46303
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiologyAmidated-kyotorphinAlzheimer’s diseaseAmyloid b peptideNovel object recognition testY-Maze alternation testLong-term potentiationMemorySynaptic plasticityCopyright © 2020 Belo, Martins, Shvachiy, Costa-Coelho, de Almeida-Borlido, Fonseca-Gomes, Neves, Vicente Miranda, Outeiro, Coelho, Xapelli, Valente, Heras, Bardaji, Castanho, Diogenes and Sebastião. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Kyotorphin (KTP, l-tyrosyl-l-arginine) is an endogenous dipeptide initially described to have analgesic properties. Recently, KTP was suggested to be an endogenous neuroprotective agent, namely for Alzheimer's disease (AD). In fact, KTP levels were shown to be decreased in the cerebrospinal fluid of patients with AD, and recent data showed that intracerebroventricular (i.c.v.) injection of KTP ameliorates memory impairments in a sporadic rat model of AD. However, this administration route is far from being a suitable therapeutic strategy. Here, we evaluated if the blood-brain permeant KTP-derivative, KTP-NH2, when systemically administered, would be effective in preventing memory deficits in a sporadic AD animal model and if so, which would be the synaptic correlates of that action. The sporadic AD model was induced in male Wistar rats through i.c.v. injection of amyloid β peptide (Aβ). Animals were treated for 20 days with KTP-NH2 (32.3 mg/kg, intraperitoneally (i.p.), starting at day 3 after Aβ administration) before memory testing (Novel object recognition (NOR) and Y-maze (YM) tests). Animals were then sacrificed, and markers for gliosis were assessed by immunohistochemistry and Western blot analysis. Synaptic correlates were assessed by evaluating theta-burst induced long term potentiation (LTP) of field excitatory synaptic potentials (fEPSPs) recorded from hippocampal slices and cortical spine density analysis. In the absence of KTP-NH2 treatment, Aβ-injected rats had clear memory deficits, as assessed through NOR or YM tests. Importantly, these memory deficits were absent in Aβ-injected rats that had been treated with KTP-NH2, which scored in memory tests as control (sham i.c.v. injected) rats. No signs of gliosis could be detected at the end of the treatment in any group of animals. LTP magnitude was significantly impaired in hippocampal slices that had been incubated with Aβ oligomers (200 nM) in the absence of KTP-NH2. Co-incubation with KTP-NH2 (50 nM) rescued LTP toward control values. Similarly, Aβ caused a significant decrease in spine density in cortical neuronal cultures, and this was prevented by co-incubation with KTP-NH2 (50 nM). In conclusion, the present data demonstrate that i.p. KTP-NH2 treatment counteracts Aβ-induced memory impairments in an AD sporadic model, possibly through the rescuing of synaptic plasticity mechanisms.This study was supported by Santa Casa da Misericórdia de Lisboa (MB37-2017) and Fundação para a Ciência e Tecnologia (FCT): PTDC/NEU-OSD/5644/2014, and PTDC/BIA-VIR/29495/2017. RFB was supported by FCT (PD/BD/114337/2016). JF-G was supported by FCT (PD/BD/114441/2016). JEC was supported by FCT (SFRH/BPD/87647/2012).FrontiersRepositório da Universidade de LisboaBelo, Rita F.Martins, Margarida L. F.Shvachiy, LianaCosta-Coelho, Tiagode Almeida-Borlido, CarolinaFonseca-Gomes, JoãoNeves, VeraVicente Miranda, HugoOuteiro, Tiago F.Coelho, Joana EXapelli, SaraValente, Cláudia A.Heras, MontserratBardaji, EduardCastanho, Miguel A. R. B.Diógenes, Maria JoséSebastião, Ana M2021-02-12T17:17:34Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/46303engFront Pharmacol. 2020 Jul 9;11:985.10.3389/fphar.2020.009851663-9812info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:48:33Zoai:repositorio.ul.pt:10451/46303Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:58:32.458288Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
title The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
spellingShingle The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
Belo, Rita F.
Amidated-kyotorphin
Alzheimer’s disease
Amyloid b peptide
Novel object recognition test
Y-Maze alternation test
Long-term potentiation
Memory
Synaptic plasticity
title_short The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
title_full The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
title_fullStr The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
title_full_unstemmed The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
title_sort The neuroprotective action of amidated-kyotorphin on amyloid β peptide-induced Alzheimer’s disease pathophysiology
author Belo, Rita F.
author_facet Belo, Rita F.
Martins, Margarida L. F.
Shvachiy, Liana
Costa-Coelho, Tiago
de Almeida-Borlido, Carolina
Fonseca-Gomes, João
Neves, Vera
Vicente Miranda, Hugo
Outeiro, Tiago F.
Coelho, Joana E
Xapelli, Sara
Valente, Cláudia A.
Heras, Montserrat
Bardaji, Eduard
Castanho, Miguel A. R. B.
Diógenes, Maria José
Sebastião, Ana M
author_role author
author2 Martins, Margarida L. F.
Shvachiy, Liana
Costa-Coelho, Tiago
de Almeida-Borlido, Carolina
Fonseca-Gomes, João
Neves, Vera
Vicente Miranda, Hugo
Outeiro, Tiago F.
Coelho, Joana E
Xapelli, Sara
Valente, Cláudia A.
Heras, Montserrat
Bardaji, Eduard
Castanho, Miguel A. R. B.
Diógenes, Maria José
Sebastião, Ana M
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Belo, Rita F.
Martins, Margarida L. F.
Shvachiy, Liana
Costa-Coelho, Tiago
de Almeida-Borlido, Carolina
Fonseca-Gomes, João
Neves, Vera
Vicente Miranda, Hugo
Outeiro, Tiago F.
Coelho, Joana E
Xapelli, Sara
Valente, Cláudia A.
Heras, Montserrat
Bardaji, Eduard
Castanho, Miguel A. R. B.
Diógenes, Maria José
Sebastião, Ana M
dc.subject.por.fl_str_mv Amidated-kyotorphin
Alzheimer’s disease
Amyloid b peptide
Novel object recognition test
Y-Maze alternation test
Long-term potentiation
Memory
Synaptic plasticity
topic Amidated-kyotorphin
Alzheimer’s disease
Amyloid b peptide
Novel object recognition test
Y-Maze alternation test
Long-term potentiation
Memory
Synaptic plasticity
description Copyright © 2020 Belo, Martins, Shvachiy, Costa-Coelho, de Almeida-Borlido, Fonseca-Gomes, Neves, Vicente Miranda, Outeiro, Coelho, Xapelli, Valente, Heras, Bardaji, Castanho, Diogenes and Sebastião. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01T00:00:00Z
2021-02-12T17:17:34Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/46303
url http://hdl.handle.net/10451/46303
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Front Pharmacol. 2020 Jul 9;11:985.
10.3389/fphar.2020.00985
1663-9812
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers
publisher.none.fl_str_mv Frontiers
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134531695935489